Loading...

Poor Prognosis With Coexistence Of EGFR T790M Mutation And Common EGFR-Activating Mutation In Non- Small Cell Lung Cancer

PURPOSE: Previous studies have shown that the presence of EGFR T790M mutation may reduce the treatment efficacy of tyrosine kinase inhibitors (TKIs) in EGFR-mutant lung cancer. However, little is known about the clinical features and outcomes of EGFR T790M mutation in pretreated patients with NSCLC....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Manag Res
Main Authors: Gao, Xuejuan, Zhao, Yanfeng, Bao, Yi, Yin, Wei, Liu, Liyu, Liu, Ruchuan, Yu, Zhengquan, Zhou, Xiao, Shuai, Jianwei
Format: Artigo
Sprog:Inglês
Udgivet: Dove 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6859090/
https://ncbi.nlm.nih.gov/pubmed/32009817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S216721
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!